| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| UNII: | HTV56CD308 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Heterotrimeric lymphotoxin LTa1b2 inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Sjogren's Syndrome | 2 | D012859 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Hepatitis C, Chronic | 1 | D019698 | ClinicalTrials |
| Multiple Sclerosis, Chronic Progressive | 1 | D020528 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 909110-25-4 |
| ChEMBL | CHEMBL1742988 |
| FDA SRS | HTV56CD308 |
CONTENTS